These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. HSV-1 amplicon vectors--simplicity and versatility. Sena-Esteves M; Saeki Y; Fraefel C; Breakefield XO Mol Ther; 2000 Jul; 2(1):9-15. PubMed ID: 10899823 [No Abstract] [Full Text] [Related]
24. Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials. Kirn D Expert Opin Biol Ther; 2001 May; 1(3):525-38. PubMed ID: 11727523 [TBL] [Abstract][Full Text] [Related]
25. Gene transfer using replication-defective retroviral and adenoviral vectors. Leber SM; Yamagata M; Sanes JR Methods Cell Biol; 1996; 51():161-83. PubMed ID: 8722476 [No Abstract] [Full Text] [Related]
26. CNS diseases amenable to gene therapy. Federoff HJ Ernst Schering Res Found Workshop; 2003; (43):117-58. PubMed ID: 12894455 [No Abstract] [Full Text] [Related]
27. Current developments in adenovirus-based cancer gene therapy. Rein DT; Breidenbach M; Curiel DT Future Oncol; 2006 Feb; 2(1):137-43. PubMed ID: 16556080 [TBL] [Abstract][Full Text] [Related]
29. The third conference on hematopoietic stem cell gene therapy: biology and technology. Emery DW; Bodine DM Mol Ther; 2002 Jun; 5(6):658-63. PubMed ID: 12027548 [No Abstract] [Full Text] [Related]
30. Gene therapy--its potential in surgery. Gojo S; Yamamoto S; Patience C; LeGuern C; Cooper DK Ann R Coll Surg Engl; 2002 Sep; 84(5):297-301. PubMed ID: 12398117 [TBL] [Abstract][Full Text] [Related]
31. Prospects for human gene therapy. Bout A Eur J Drug Metab Pharmacokinet; 1996; 21(2):175-9. PubMed ID: 8839692 [TBL] [Abstract][Full Text] [Related]
32. Provocative gene therapy strategy for the treatment of hepatocellular carcinoma. Askari F; Wilson J Hepatology; 1992 Jul; 16(1):273-4. PubMed ID: 1319955 [No Abstract] [Full Text] [Related]
33. An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells. Liu RY; Zhou L; Zhang YL; Huang BJ; Ke ML; Chen JM; Li LX; Fu X; Wu JX; Huang W Biochem Biophys Res Commun; 2013 Dec; 442(3-4):171-6. PubMed ID: 24269822 [TBL] [Abstract][Full Text] [Related]
34. Recent advances in oncolytic adenovirus therapies for cancer. Rosewell Shaw A; Suzuki M Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906 [TBL] [Abstract][Full Text] [Related]
35. Virus vector design in gene therapy. Günzburg WH; Salmons B Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189 [TBL] [Abstract][Full Text] [Related]
36. Preparation of retroviral vectors for cell-cycle-targeted gene therapy of lung cancer. Claudio PP; Giordano A Methods Mol Med; 2003; 75():591-605. PubMed ID: 12407766 [No Abstract] [Full Text] [Related]
37. Gene therapy for the treatment of oral squamous cell carcinoma. Xi S; Grandis JR J Dent Res; 2003 Jan; 82(1):11-6. PubMed ID: 12508038 [TBL] [Abstract][Full Text] [Related]
38. Phase I trial of intravenous Ad5CRT in patients with liver metastasis of gastrointestinal cancers. Lee SJ; Shin SP; Lee SH; Kang JW; Kook MC; Kim IH; Kim HK Cancer Gene Ther; 2019 May; 26(5-6):174-178. PubMed ID: 30393375 [TBL] [Abstract][Full Text] [Related]
39. Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease. Dunbar CE Annu Rev Med; 1996; 47():11-20. PubMed ID: 8712765 [TBL] [Abstract][Full Text] [Related]
40. Human cancer and gene therapy. Schmidt-Wolf G; Schmidt-Wolf IG Ann Hematol; 1994 Dec; 69(6):273-9. PubMed ID: 7993934 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]